Biolinq raises $100M to support FDA approval of its color-changing glucose biosensor for people with Type 2 diabetes not on insulin.
Abbott is one of several firms targeting wellness enthusiasts with a CGM that can be used by non-diabetics to track metabolic health.
Allez Health has raised $60 million in a Series A for its continuous glucose monitoring (CGM) biosensor platform for connected digital health platforms.
Garmin reported $343 million in revenue in its fitness category during Q1, setting a new record amid strong demand for advanced wearables.
Biolinq's “barely there” wearable touts a color-changing interface for quick glucose insights without the need for a secondary device.
Sign Up to Our Newsletter
